Evidence map›Paper›PMID 35538057›Full record

ArticleNature communications2022

Archival influenza virus genomes from Europe reveal genomic variability during the 1918 pandemic.

Livia V Patrono, Bram Vrancken, Matthias Budt, Ariane Düx, Sebastian Lequime, Sengül Boral, M Thomas P Gilbert, Jan F Gogarten, Luisa Hoffmann, David Horst and 16 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Recovery of an 18bioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 11 institutions in 9 countries.

Livia V Patrono *Epidemiology of Highly Pathogenic Microorganisms, Robert Koch Institute, Berlin, Germany.
Bram Vrancken *Laboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0001-6547-5283
Matthias Budt *Unit 17 Influenza and other Respiratory Viruses, Robert Koch Institute, Berlin, Germany.
Ariane DüxEpidemiology of Highly Pathogenic Microorganisms, Robert Koch Institute, Berlin, Germany.
Sebastian LequimeCluster of Microbial Ecology, Groningen Institute for Evolutionary Life Sciences, University of Groningen, Groningen, The Netherlands.ORCID http://orcid.org/0000-0002-3140-0651
Sengül BoralInstitute for Pathology, Charité, Berlin, Germany.
M Thomas P GilbertCenter for Evolutionary Hologenomics, The GLOBE Institute, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-5805-7195
Jan F GogartenEpidemiology of Highly Pathogenic Microorganisms, Robert Koch Institute, Berlin, Germany.
Luisa HoffmannUnit 17 Influenza and other Respiratory Viruses, Robert Koch Institute, Berlin, Germany.
David HorstInstitute for Pathology, Charité, Berlin, Germany.
Kevin MerkelEpidemiology of Highly Pathogenic Microorganisms, Robert Koch Institute, Berlin, Germany.
David MorensOffice of the Director, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Baptiste PrepointViral Evolution, Robert Koch Institute, Berlin, Germany.ORCID http://orcid.org/0000-0002-2807-7662
Jasmin SchlotterbeckViral Evolution, Robert Koch Institute, Berlin, Germany.
Verena J SchuenemannInstitute of Evolutionary Medicine, University of Zurich, Zurich, Switzerland.
Marc A SuchardDepartment of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0001-9818-479X
Jeffery K TaubenbergerViral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-9694-7228
Luisa TenkhoffUnit 17 Influenza and other Respiratory Viruses, Robert Koch Institute, Berlin, Germany.
Christian UrbanInstitute of Evolutionary Medicine, University of Zurich, Zurich, Switzerland.
Navena WidulinBerlin Museum of Medical History, Charité, Berlin, Germany.
Eduard WinterPathological-anatomical collection in the Narrenturm, Natural History Museum of Vienna, Vienna, Austria.
Michael WorobeyDepartment of Ecology and Evolutionary Biology, University of Arizona, Tucson, AZ, USA.ORCID http://orcid.org/0000-0002-3578-1367
Thomas SchnalkeBerlin Museum of Medical History, Charité, Berlin, Germany.ORCID http://orcid.org/0000-0003-2073-2914
Thorsten WolffUnit 17 Influenza and other Respiratory Viruses, Robert Koch Institute, Berlin, Germany.ORCID http://orcid.org/0000-0001-7688-236X
Philippe LemeyLaboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0003-2826-5353
Sébastien Calvignac-SpencerEpidemiology of Highly Pathogenic Microorganisms, Robert Koch Institute, Berlin, Germany. calvignacs@rki.de.ORCID http://orcid.org/0000-0003-4834-0509
Robert Koch Institute · DECharité - Universitätsmedizin Berlin · DERega Institute for Medical Research · BEUniversity of Zurich · CHNational Institute of Allergy and Infectious Diseases · USNatural History Museum Vienna · ATOffice of the Director · USUniversity of Arizona · USUniversity of California, Los Angeles · USUniversity of Copenhagen · DKUniversity of Groningen · NL

Funding

Technology CoreU19AI135995 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI Kristian Graugaard Andersen · 2018 to 2026
$32.0M
Influenza Viral PathogenesisZIAAI000986 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI TAUBENBERGER, JEFFERY · 2009 to 2025
$30.0M
Genomics, GPUs, and Next Generation Computational StatisticsR01HG006139 · NHGRI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SOBEL, ERIC · 2011 to 2023
$5.1M
Gates Foundation INV-004212NHGRI NIH HHS R01 HG006139NIAID NIH HHS U19 AI135995Wellcome TrustWellcome Trust 206298/Z/17/Z
6 · The paper itself

Abstract

The 1918 influenza pandemic was the deadliest respiratory pandemic of the 20th century and determined the genomic make-up of subsequent human influenza A viruses (IAV). Here, we analyze both the first 1918 IAV genomes from Europe and the first from samples prior to the autumn peak. 1918 IAV genomic diversity is consistent with a combination of local transmission and long-distance dispersal events. Comparison of genomes before and during the pandemic peak shows variation at two sites in the nucleoprotein gene associated with resistance to host antiviral response, pointing at a possible adaptation of 1918 IAV to humans. Finally, local molecular clock modeling suggests a pure pandemic descent of seasonal H1N1 IAV as an alternative to the hypothesis of origination through an intrasubtype reassortment.

Indexed as

Influenza A virusInfluenza A Virus, H1N1 SubtypeInfluenza, HumanGenome, ViralGenomicsHumans

Identifiers

PMID35538057
PMCPMC9090925
OpenAlexW4229443008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.